慢性粒细胞性白血病的症状和体征往往发展缓慢。
目的探讨JWA基因表达与慢性粒细胞性白血病（CML）的相关意义。
Objective The purpose of this study is to find the relationship and significance between the expression of JWA gene and chronic myelogenous leukemia (CML).
相对于急性白血病，慢性淋巴细胞白血病和慢性粒细胞性白血病通常进展缓慢。
Chronic lymphocytic leukemia and chronic myelogenous leukemia usually progress slowly compared to acute leukemias.
有些病人在常规体检的血液检查后才知道他们患有慢性淋巴细胞白血病或慢性粒细胞性白血病。
Some patients learn they have CLL or CML after a blood test as part of a regular checkup.
此外，还对部分配合物进行体外抗癌活性测试研究，实验靶细胞是人慢性粒细胞性白血病K562细胞。
The research showed that the complexes can inhibit K562 tumor cell's growth, generation and induce apoptosis.
结论：(1)供者白细胞的输注能使某些BMT后慢性粒细胞性白血病遗传学及血液学复发患者完全缓解。
Conclusion: (1) Donor derived leukocyte infusion can induce CML post BMT to cytogenetic and hematological CR. It has also therapeutic effects on acute leukemia relapse but is less sustained.
NBA史上得分王卡里姆·阿卜杜尔-贾巴尔日前在接受《洛杉矶时报》的采访时披露，自己被确诊患上慢性粒细胞性白血病。
All-time NBA top scorer Kareem Abdul-Jabbar has been diagnosed with chronic myeloid leukemia, he said during an interview with the Los Angeles Times.
包括药物的发明者BrianDruker博士在内的一个由来自美国和欧洲的研究人员组成的团队跟踪研究了454位慢性粒细胞性白血病慢性期患者，这些患者使用伊马替尼已经超过6年。
A team of researchers from the U. s. and Europe, including the drug's creator, Brian Druker, MD, followed 454 patients with chronic-phase CML taking imatinib for more than six years.
慢性粒细胞白血病是一种造血干细胞克隆性增殖所致的骨髓增殖性疾病。
Chronic myelocytic leukemia is a clonal proliferation of hematopoietic stem cells caused by myeloproliferative disorders.
须与类白血病相鉴别，可用的检测是粒细胞碱性磷酸酶(LAP)，慢性髓性白血病较低而类白血病反应较高。
A useful test to help distinguish this disease is the leukocyte alkaline phosphatase (LAP) score, which should be low with CML and high with a leukemoid reaction.
须与类白血病相鉴别，可用的检测是粒细胞碱性磷酸酶(LAP)，慢性髓性白血病较低而类白血病反应较高。
A useful test to help distinguish this disease is the leukocyte alkaline phosphatase (LAP) score, which should be low with CML and high with a leukemoid reaction.
应用推荐